Wednesday, December 28, 2016

BRIEF-Ascendance Biotechnology licenses the right to manufacture and sell cytiva cardiomyocytes

* Ascendance biotechnology licenses the right to

manufacture, market and sell cytiva cardiomyocytes

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)